The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
GeparOLA: A randomized phase II trial to assess the efficacy of paclitaxel and olaparib in comparison to paclitaxel/carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant chemotherapy in patients (pts) with HER2-negative early breast cancer (BC) and homologous recombination deficiency (HRD).
 
Peter A. Fasching
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Hexal; Merck Sharp & Dohme; Myelo Therapeutics GmbH; Novartis; Pfizer; Puma Biotechnology; Roche; Teva
Research Funding - BioNTech (Inst); Novartis (Inst)
 
Christian Jackisch
Consulting or Advisory Role - AstraZeneca; Genomic Health; Genomic Health; Novartis; Roche; Tesaro
Research Funding - Genomic Health (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Novartis; Roche
 
Kerstin Rhiem
Consulting or Advisory Role - Tesaro
Travel, Accommodations, Expenses - AstraZeneca
 
Andreas Schneeweiss
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche Pharma AG; Tesaro
Research Funding - Abbvie; Celgene (Inst); Molecular Partners; Roche Pharma AG (Inst)
Expert Testimony - AstraZeneca; Roche
Travel, Accommodations, Expenses - Celgene; Roche
 
Peter Klare
No Relationships to Disclose
 
Claus Hanusch
Consulting or Advisory Role - Amgen; AstraZeneca; Celgene; Novartis; Pfizer; Roche
Speakers' Bureau - Celgene; Lilly; Novartis; Pfizer; Roche
 
Jens Bodo Huober
Honoraria - AstraZeneca; Celgene; Lilly; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Celgene; Lilly; Novartis; Pfizer; Roche
Research Funding - Celgene (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Celgene; Celgene; Novartis; Pfizer; Roche
 
Theresa Link
Honoraria - MSD; Novartis; Pfizer; Roche; Tesaro
Consulting or Advisory Role - Amgen (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Pfizer; Pharma Marathi; Roche
 
Michael Untch
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; Eisai; Lilly; Merck Sharp & Dome; Mundipharma; Myriad Genetics; Pfizer; Roche; Teva
Consulting or Advisory Role - Abbvie (Inst); Amgen (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); MSD (Inst); Mundipharma (Inst); Pfizer (Inst); Roche (Inst)
 
Sabine Schmatloch
No Relationships to Disclose
 
Carsten Denkert
Stock and Other Ownership Interests - Sividon Diagnostics
Honoraria - Amgen; AstraZeneca; Celgene; Daiichi Sankyo; MSD; Novartis; Pfizer; Roche; Teva
Consulting or Advisory Role - Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Daiichi Sankyo (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Teva (Inst)
Research Funding - VMscope (Inst)
Patents, Royalties, Other Intellectual Property - EP18209672
 
Andrea Stefek
No Relationships to Disclose
 
Christoph Uleer
Honoraria - Novartis; Roche
Consulting or Advisory Role - Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Gabriele Doering
No Relationships to Disclose
 
Knut Engels
No Relationships to Disclose
 
Fenja Seither
No Relationships to Disclose
 
Jens Uwe Blohmer
Honoraria - Amgen; AstraZeneca; Genomic Health; MSD Oncology; Myriad Genetics; Novartis/Pfizer; Pfizer; Roche; Sonoscape
Travel, Accommodations, Expenses - Pfizer; Roche
 
Sibylle Loibl
Consulting or Advisory Role - AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst)
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Seagen (Inst); Teva (Inst); Vifor Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Patent Pending EP14153692.0 (Inst)